Akums Drugs and Pharmaceutical (AKUMS) — Cash Flow-to-Debt Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow-to-Debt Ratio of 0.44x as of March 2025, meaning its operating cash flow of Rs4.65 Billion could theoretically repay 0% of its total liabilities (Rs10.50 Billion) in one year. See AKUMS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Akums Drugs and Pharmaceutical Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Akums Drugs and Pharmaceutical across 4 annual periods. Also explore net asset growth rate of Akums Drugs and Pharmaceutical to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year debt coverage analysis for Akums Drugs and Pharmaceutical. For market capitalisation and broader financial context, see AKUMS market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | Rs4.65 Billion | Rs10.50 Billion | ▲ +148.6% |
| 2024 | 0.18x | Rs4.98 Billion | Rs27.96 Billion | ▲ +156.6% |
| 2023 | 0.07x | Rs1.77 Billion | Rs25.43 Billion | ▲ +432.9% |
| 2022 | 0.01x | Rs318.54 Million | Rs24.44 Billion | — |